You are subscribed to the Dermatology Times eNews.
Print Subscribe
eNewsletter Subscribe
Digital Edition Subscribe
February 9, 2015
Web Version | Digital Edition | Share with a colleague
Like Tweet
THIS MONTH IN SKIN CANCER
How melanoma cells resist combo therapy. » MORE
ADVERTISEMENT
Looking to reach your patients in new way? The right mobile health tool can empower your practice and help utilize clinic time efficiently. Click here to request a free demo of TouchCare today.
Aldoxorubicin demonstrates effectiveness against a range of tumors. » MORE
A new understanding of the complexity of tumor biology. » MORE
Why this could obviate the need for more costly, time-consuming treatment methods. » MORE
Related Articles
Small molecule inhibitor shows promise
Opportunities, challenges with new treatments for advanced cancer
New law aims to streamline FDA sunscreen-approval process
Diagnosing, managing aBCC in elderly patients
FDA accelerates approval of melanoma drug
New Job Opportunities
AZ - Arizona Skin & Laser
CA - Integrated Dermatology
CA - LA Laser Center
CA - MedDerm Associates
CT - Integrated Dermatology
CO - Integrated Dermatology
District of Columbia - Integrated Dermatology
FL - Betty Bellman, MD PA
FL - Integrated Dermatology
FL - Palm Beach Dermatology
IL - Integrated Dermatology
MI - Fivenson Dermatology PLLC
National - Integrated Dermatology
National - Leavitt Management Group
NC - Integrated Dermatology
NJ - David A High, MD
NM - Integrated Dermatology
NY - Company Confidential
OK - Tulsa Cancer Institute
OR - Cynthia Dreyer MD
PA - Dermatology Associates of Lancaster
UT - Integrated Dermatology
Editorial Questions? Contact the Editorial Team. Click Here. Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.
Like
Tweet
